跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
OFIRMEV - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
OFIRMEV
Authorized
STANDARD
OFIRMEV
Mallinckrodt Hospital Products Inc.
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
82e0405a1a9084ef
Company
Mallinckrodt Hospital Products Inc.
Type
Standard
Approval Details
Approval Id
82e0405a1a9084ef
Drug Approval Canada Name
OFIRMEV
Product Name
OFIRMEV
Status
Cancelled Pre Market
Status Date
2018-08-07
Din
02408066
Drug Class
Human
Dosage Form
Solution
Route Of Administration
Intravenous
Schedule
Prescription
Ahfs
28:08.92
Atc Original
N02BE01 ACETAMINOPHEN (PARACETAMOL)
Atc Name
n 02 be 01
Aig Number
0102009015
Company Name
Mallinckrodt Hospital Products Inc.
Company Address
440 Route 22 East, Bridgewater, New Jersey, United States, 08807
Company Detail Path
/organization/mallinckrodt-hospital-products-inc
Company Information
Pharmaceutical Company Name
Mallinckrodt Hospital Products Inc.
Country Name
United States
Province Name
Missouri
City Name
hazelwood,missouri,country_us
Address
675 James S McDonnell Blvd
Active Ingredients
ACETAMINOPHEN
10 MG / ML
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
82e0405a1a9084ef
Type
Standard
Back to Health Canada Approvals